Provided by Tiger Fintech (Singapore) Pte. Ltd.

Actuate Therapeutics Inc

7.35
-0.1100-1.47%
Post-market: 7.350.00000.00%16:05 EDT
Volume:26.06K
Turnover:192.62K
Market Cap:143.56M
PE:-2.26
High:7.49
Open:7.27
Low:7.26
Close:7.46
Loading ...

Actuate Therapeutics Inc: to Report Topline Data From Phase 2 Trial of Elraglusib in 1H 2025

THOMSON REUTERS
·
07 Jan

Actuate Therapeutics Receives Ema Orphan Medicinal Product Designation for Elraglusib for the Treatment of Pancreatic Cancer

THOMSON REUTERS
·
07 Jan

Actuate Therapeutics Receives EMA Orphan Medicinal Product Designation for Elraglusib for the Treatment of Pancreatic Cancer

GlobeNewswire
·
07 Jan

BRIEF-Actuate Therapeutics Announces Interim Phase 2 Data Of Elraglusib

Reuters
·
17 Dec 2024

Actuate Therapeutics Shares Rise 12% on Positive Phase 2 Trial to Treat Metastatic Pancreatic Ductal Cancer

Dow Jones
·
17 Dec 2024

Actuate Therapeutics Reports Phase 2 Trial Success for Elraglusib in Metastatic Pancreatic Cancer

MT Newswires Live
·
17 Dec 2024

Actuate Therapeutics announces interim Phase 2 data of elraglusib

TIPRANKS
·
17 Dec 2024

Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

THOMSON REUTERS
·
17 Dec 2024

Actuate Therapeutics Inc - Statistical Significance Met on Primary Endpoints in Phase 2 Trial

THOMSON REUTERS
·
17 Dec 2024

Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

THOMSON REUTERS
·
17 Dec 2024

Actuate Therapeutics Inc - Elraglusib in Combination With Gnp Shows Favorable Risk-Benefit Profile

THOMSON REUTERS
·
17 Dec 2024

Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

GlobeNewswire
·
17 Dec 2024

RBA resists call for Christmas rate cut, keeps things on-hold despite GDP slump

The Market Herald
·
10 Dec 2024

The staggering number of Aussies set to lose their jobs to AIWithout immediate action, Australian workers are highly vulnerable to mass job losses.2 min read

7NEWS
·
10 Dec 2024

Actuate Therapeutics to Join Russell 2000 Index; Shares Up Pre-Bell

MT Newswires Live
·
26 Nov 2024

Actuate Therapeutics added to Russell 2000 Index

TIPRANKS
·
26 Nov 2024